GlassScriptPhysician profile
Mark A Casillas
NPI 1245458082
$3,867.45
in general payments reported to CMS, 2019-2025
37 companies · $361 in 2025
The $361 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,227 · 2020: $417 · 2021: $290 · 2022: $514 · 2023: $504 · 2024: $554 · 2025: $361.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,419.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,418.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $876.22 | 2019-2022 | |
| Ethicon US, LLC | $346.10 | 2019-2025 | Vistaseal, Echelon; Endopath, Ethicon |
| Medtronic, INC. | $338.03 | 2021-2024 | Interstim, Gi Genius, Gia |
| La Jolla Pharmaceutical Company | $253.55 | 2020-2024 | Xerava |
| Medtronic USA, INC. | $230.78 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $227.86 | 2019-2025 | Gattex |
| Kerecis Limited | $209.76 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Innovation Technologies INC | $115.37 | 2021-2023 | Irrisept |
| Mallinckrodt Enterprises LLC | $105.59 | 2019 | |
| Abbvie INC. | $103.88 | 2024-2025 | |
| Baxter Healthcare | $92.35 | 2023-2025 | Perclot, Tisseel |
| Integra Lifesciences Corporation | $91.24 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Olympus America INC. | $83.74 | 2019-2023 | Olympus |
| Boston Scientific Corporation | $75.17 | 2019-2020 | |
| Stryker Corporation | $66.25 | 2024 | 1688, Eikon, Spy-Phi System |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $57.57 | 2025 | Restrata Wound Matrix |
| Thd America, INC. | $50.80 | 2024-2025 | |
| Allergan, INC. | $48.72 | 2020-2021 | |
| Convatec INC. | $48.61 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $42.89 | 2019-2020 | |
| Ambu INC. | $40.64 | 2023 | |
| Myriad Genetic Laboratories, INC. | $32.65 | 2022 | |
| Covidien LP | $32.52 | 2019 | |
| Shire North American Group INC | $31.05 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $31.05 | 2023 | Seglentis |
| Ferring Pharmaceuticals INC. | $28.78 | 2024 | Rebyota |
| Tela Bio, INC. | $27.04 | 2019 | |
| Amgen INC. | $24.33 | 2019 | |
| Axonics, INC. | $22.94 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.40 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $21.67 | 2025 | |
| Acell, INC. | $17.61 | 2019 | |
| Sanara Medtech INC. | $15.43 | 2022 | |
| Medical Device Business Services, INC. | $14.67 | 2020 | |
| Incyte Corporation | $13.71 | 2019 | |
| Eisai INC. | $13.29 | 2019 | |
| Cook Medical LLC | $13.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Casillas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.